![]() |
||||||
|
![]() | |
![]() | |
![]() | Differntial gene expression between RNA A-to-I edited tumor samples versus normal samples |
![]() | |
![]() | |
![]() | The effects of the RNA editing to the stability of the RNA structures |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Editing gene: CLDN9 (CAeditome ID:9080) |
Gene summary for CLDN9 |
![]() |
Gene information | Gene symbol | CLDN9 | Gene ID | 9080 |
Gene name | claudin 9 | |
Synonyms | DFNB116 | |
Cytomap | 16p13.3 | |
Type of gene | protein-coding | |
Description | claudin-9 | |
Modification date | 20210518 | |
UniProtAcc | O95484 | |
Context |
![]() |
Gene | GO ID | GO term | PubMed ID |
CLDN9 | GO:0005886 | Claudin-9 | 20375010 |
CLDN9 | GO:0030054 | Claudin-9 | 0000052 |
CLDN9 | GO:0043231 | Claudin-9 | 0000052 |
Top |
RNA A-to-I events for CLDN9 |
![]() |
![]() |
![]() |
![]() |
CAediting_1080646(3013537, +), CAediting_1080647(3013556, +), CAediting_1080648(3013562, +), CAediting_1080649(3013796, +), CAediting_1080650(3013807, +), CAediting_1080651(3013808, +), |
Top |
RNA editing positional annotations for CLDN9 using Annovar |
![]() |
CAeditome ID | Position | Variant type | ENST | NTchange | AAchange | SIFT_score | Polyphen2_HVAR_score | PROVEAN_pred |
CAediting_1080646 | chr16_3013537_+ | nonsynonymous SNV | ENST00000445369.2 | c.A175G | p.T59A | D | D | D |
CAediting_1080647 | chr16_3013556_+ | nonsynonymous SNV | ENST00000445369.2 | c.A194G | p.K65R | D | P | D |
CAediting_1080648 | chr16_3013562_+ | nonsynonymous SNV | ENST00000445369.2 | c.A200G | p.Y67C | D | D | D |
CAediting_1080650 | chr16_3013807_+ | nonsynonymous SNV | ENST00000445369.2 | c.A445G | p.N149D | T | B | D |
CAediting_1080651 | chr16_3013808_+ | nonsynonymous SNV | ENST00000445369.2 | c.A446G | p.N149S | T | P | D |
![]() |
CAeditome ID | Position | Variant type |
CAediting_1080646 | chr16_3013537_+ | exonic |
CAediting_1080647 | chr16_3013556_+ | exonic |
CAediting_1080648 | chr16_3013562_+ | exonic |
CAediting_1080649 | chr16_3013796_+ | exonic |
CAediting_1080650 | chr16_3013807_+ | exonic |
CAediting_1080651 | chr16_3013808_+ | exonic |
![]() |
CAeditome ID | Position | Repeat family | Repeat sub family | Repeat name |
Top |
RNA A-to-I editing events in the alternative splicing sites for CLDN9 |
![]() |
AStype | CAeditomID | Editing position | AS position | AS direction | Exonic location | Wildtype sequence | Wildtype splicing strength | RNA edited sequence | RNA edited splicing strength |
![]() |
![]() |
Top |
Differntial gene expression between RNA A-to-I edited versus non-edited samples for CLDN9 |
![]() * The grey color means N/A. |
![]() |
![]() * Click on the image to enlarge it in a new window. |
Top |
Protein coding region RNA A-to-I editings for CLDN9 |
![]() * Click on the image to enlarge it in a new window. |
Top |
The effects of the RNA editing to the miRNA binding sites for CLDN9 |
**If you are searching a miRNA gene with RNA editing events in its seed regions, please see the search pages of miRNA targets to discover the effects of this RNA editing event to miRNA regulations. For more information, please check the files in the Download page. |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
CAediting_748296 | chr10_51299626_+ | ENSG00000213937.3 | ENST00000445369 | hsa-miR-605-3p | 3014404 | 3014410 | 7mer-m8 | 3014390 | 3014411 | 140 | -14.23 |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
Top |
The effects of the RNA editing to the stability of the RNA structures for CLDN9 |
![]() * Click on the image to enlarge it in a new window. |
ENST | ENST type | RNA structure without RNA A-to-I editing. | RNA structure with RNA A-to-I editing. |
![]() |
CAeditom_ID | ENST | Editing_Position | MFE_withoneAI | MFE_withoutAI | MFE_withmultipleAI |
Top |
Relation with ADAR for CLDN9 |
![]() |
Cancer | CAeditomID | position | ADAR1 (p-val) | ADAR1 (coeff.) | ADAR2 (p-val) | ADAR2 (coeff.) | ADAR3 (p-val) | ADAR3 (coeff.) |
Top |
Relation with cancer stages for CLDN9 |
![]() |
Cancer | Stage_type | CAeditomID | position | P-val | Coeff. |
Top |
Relation with survival for CLDN9 |
![]() |
Cancer | CAeditomID | position | KMpvalue | Coxpvalue | CoxHR |
Top |
RelatedDrugs for CLDN9 |
![]() (DrugBank Version 5.1.8 2021-01-03) |
Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CLDN9 |
![]() (DisGeNet 7.0) |
Gene | Disease ID | Disease name | # pubmeds | Source |
CLDN9 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
CLDN9 | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |